Dr David Walcott shares vision for tech-driven healthcare at WEF 2024 in Davos
Driven by the progress made on his long-standing mission to eradicate healthcare issues in emerging markets like the Caribbean and Latin America, medical doctor and healthcare investor Dr David Walcott has, for the fourth consecutive time, been invited to share his journey in Davos, where the 54th staging of the Annual Meeting of the WEF is being held.
The conference, which runs from January 15 through January 19, will welcome over 100 governments, major international organisations, 1,000 forum partners, as well as civil society leaders, experts, youth representatives, social entrepreneurs, and news outlets. Dr Walcott remains the sole Jamaican to be invited to the event, according to a press release.
Dr Walcott, who is also the founder of Novamed, joins Mary Carbajal, CEO of B1OS; Sandra Lindsay, VP of Public Health at Northwell health; Smriti Kirubanandan, Robotics and Public Health Executive and Megan Greenfield, Healthcare Partner at McKinsey and Company in a panel discussion powered by Northwell Health – New York’s largest healthcare provider- on Tuesday, January 16.
Speaking on the topic ‘Healthcare Technology and Equity’. The subject matter is timely for Dr Walcott who played a pivotal role in Caribbean Health Systems Limited’s acquisition of the long-standing health institution Medical Associates Limited in Kingston, Jamaica. That hospital has since undergone a phased transformation of some medical processes aimed at reducing operating costs, boosting productivity, and improving patient outcomes.
Dr Walcott said: “In under-resourced environments like Jamaica, it’s important for us to be creative and flexible in how we deliver healthcare. Good healthcare services usually come at a high cost, but we can minimise the costs to the patient by equipping our medical facility with the appropriate technology that will lead to greater efficiencies in our business.”
He added that since CHS’s acquisition of Medical Associates, the parent company has so far invested in technology to optimise electronic medical records, amid a general upgrade of the hospital’s lobbying area and specific departments, in accordance with the directors’ vision to transform Medical Associates into a first-world facility.
CHS, which is jointly owned by Novamed, FirstRock Real Estate Investments Limited (FRRE) and Health Ventures Limited, completed the acquisition of Medical Associates in March 2023. Dr Walcott alongside his business partners continues to explore more ways to incorporate cutting-edge technology in the refreshed Medical Associates institution.
He will speak on further ambitions he has for medical care in Jamaica and the wider Caribbean and Latin America region during the panel discussion on Tuesday. Later on, Dr Walcott will join an exclusive list of guests for a dinner arranged by a strategic partner of WEF, McKinsey and Company.
Dr Walcott said: “It’s evident that technology will play a pivotal role in the future of healthcare, and an evening dinner presents the perfect opportunity for us to connect on a more granular level about the various aspects of technology including medical innovation, efficiency, data security, and the overall impact on patient care.”
Like in prior years, WEF 2024 promises to be a unique opportunity to connect with an extraordinary number of clients and key decision-makers. The four-day event is packed with thought-provoking formal sessions, one-on-one meetings, and unmatched networking opportunities.
Three years ago, Dr Walcott was named a Young Global Leader by the World Economic Forum, which highlighted him as one of the world’s most promising leaders under the age of 40. Additionally, Dr Walcott continues to exude solid leadership qualities and sharpened business sense.
Aside from his interests in Novamed and Medical Associates, Dr Walcott also has a controlling interest in Summit, the rebranded Knutsford Court Hotel, Windward Medical Centre (InterMed Co) through Novamed.